Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00290654 · ClinicalTrials.gov registry record · Phase 2
Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ
A Phase 2 study, sponsored by Masonic Cancer Center, University of Minnesota.
- Terminated
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT00290654 is a Phase 2 study that was terminated before completion, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 45 participants.
The verdict
NCT00290654, a Phase 2 study, was terminated before completion, sponsored by Masonic Cancer Center, University of Minnesota.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
RATIONALE: Internal radiation uses radioactive material placed directly into or near a tumor to kill tumor cells. Giving internal radiation therapy using a special radiation therapy device may kill any tumor cells that remain after surgery. PURPOSE: This phase II trial is studying how well internal radiation therapy after lumpectomy works in treating women with ductal carcinoma in situ.
Interventions
- DRUG Tamoxifen
- PROCEDURE Lumpectomy
- RADIATION brachytherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2002-12 |
| Est. Completion | 2013-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00290654
The ClinicalTrials.gov registry entry for NCT00290654 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Tamoxifen is the first listed.
NCT00290654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00290654 about?
NCT00290654 is a clinical study titled "Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ". RATIONALE: Internal radiation uses radioactive material placed directly into or near a tumor to kill tumor cells. Giving internal radiation therapy using a special radiation therapy device may kill any tumor cells that remain after surgery. PURPOSE: This phase II trial is studying how well internal...
What is the current status of trial NCT00290654?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2002-12. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00290654?
The interventions under investigation include: Tamoxifen (DRUG), Lumpectomy (PROCEDURE), brachytherapy (RADIATION).
Who is sponsoring clinical trial NCT00290654?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.